1. GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control
   Takashi Nomiyama et al, 2016, Expert Review of Endocrinology & Metabolism CrossRef
2. Effects of novel antidiabetes agents on apoptotic processes in diabetes and malignancy: Implications for lowering tissue damage
   Habib Yaribeygi et al, 2019, Life Sciences CrossRef
3. Expression of Hypoxia-Inducible Factors in Different Stages of Pancreatic Tumor Progression
   Jung Hwa Jung et al, 2020, Reports CrossRef
4. Everestmab, a novel long-acting GLP-1/anti GLP-1R nanobody fusion protein, exerts potent anti-diabetic effects
   Hongchao Pan et al, 2020, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
5. The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular
   Junyuan Deng et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
6. GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death
   Wu Li et al, 2024, Journal of Obstetrics and Gynaecology CrossRef
7. GI Peptides, Energy Balance, and Cancer
   Debora S. Bruno et al, 2017, Adipocytokines, Energy Balance, and Cancer CrossRef